AI in Pediatrics

Pediatric AI covers the same broad tasks as adult medicine, but each is harder.

Growth and development tracking has always depended on reference charts, such as WHO and CDC growth curves. AI can add pattern detection across repeated measurements, for example flagging a child whose weight is crossing percentile lines in a way that warrants attention, or estimating bone age from a hand X-ray. Automated bone age tools have been used clinically in Europe for years and are a good example of a narrow, well-defined task that suits machine learning.

Pediatric imaging uses lower radiation doses and smaller anatomy, and normal appearances change with age: a growth plate in a ten-year-old is expected, while a similar line in an adult may be a fracture. A model trained on adult X-rays can misread these.

NICU monitoring is one of the older success stories. The HeRO monitor analyzes heart rate characteristics to estimate sepsis risk in premature infants, and a large randomized trial published in 2011 found reduced mortality in very low birth weight infants whose clinicians could see the score. Deep learning is also used to screen for retinopathy of prematurity from retinal images.

Developmental diagnosis gained a landmark in 2021, when the FDA authorized Cognoa's Canvas Dx as an aid for diagnosing autism in young children. It supports, rather than replaces, clinician judgment.

Why is building pediatric AI harder? Datasets are small because children are healthier on average and rare diseases are spread thin. Age groups differ so much that a newborn and a teenager are almost different populations. Consent involves parents and, increasingly, the child's own assent, and privacy rules are stricter. Many AI devices cleared by regulators were never evaluated in children at all. A common misconception is that an adult-tested tool can simply be used on children; it usually needs separate validation.